Drug Pipeline

Danicopan Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
1
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT05982938
Danicopan Early Access Program		 Trial sites expanded: 0 -> 15 locations
Active Studies by Phase
Phase 3
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05389449 A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement… Paroxysmal Nocturnal Hemoglobinuria Active, Not Recruiting
Not specified
NCT07413250 Assess Long-Term Safety of Danicopan Add-on Therapy in Participants With Paroxysmal… Paroxysmal Nocturnal Hemoglobinuria Active, Not Recruiting
NCT07413679 Long-term Safety of Danicopan: IPIG Registry-based Cohort Study Paroxysmal Nocturnal Hemoglobinuria Active, Not Recruiting
Sponsors Running Danicopan Trials
Alexion Pharmaceuticals, Inc. (3)
Get alerts when Danicopan trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free